We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Humira biosimilar

News List

NHS saving £300m with Humira biosimilar deal pharmaphorum
November 30, 2018
The NHS is to save £300 million after striking deals with several manufacturers of low cost biosimilars of AbbVie’s Humira inflammatory diseases drug.....
Mylan, Fujifilm score EU thumbs-up for Humira biosimilar, putting more pressure on AbbVie fiercepharma
September 21, 2018
AbbVie and its investors have been fretting over the potential impact of biosimilar competition to Humira—the world’s top-selling drug, with more than $18 billion a year in sales—and now they have another contender to worry about.
Boehringer’s Humira biosimilar wins US green light pharmatimes
August 31, 2017
US regulators have approved Boehringer Ingelheim’s Cyltezo, a biosimilar to AbbVie’s Humira, in a pre-filled syringe for the treatment of multiple chronic inflammatory diseases